Impact of different immunosuppressive protocols on clinical outcomes in obese kidney transplant recipients: a propensity score–matched analysis
Nephrology Dialysis Transplantation · 2023
DOI: 10.1093/ndt/gfad014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Lina Maria Serna-Higuita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Epidemiology and Applied Biostatistics, Medical University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Although obesity has become a significant problem in transplantation medicine, the impact of different immunosuppressive protocols on clinical outcomes in obese transplant recipients remains unclear.
Methods
We performed an analysis of the Scientific Registry of Transplant Recipients database. Kidney transplant recipients were categorized according to body mass index (BMI) categories and immunosuppressive protocols: (i) tacrolimus/mycophenolate mofetil (Tac-MMF), (ii) mTOR-inhibitor/Tac (mTORi-Tac), (iii) mTORi/cyclosporin (mTORi-Cyc) and (iv) mTORi-MMF.
Results
Graft recipients with advanced obesity (BMI ≥35 kg/m2) exhibited significantly lower rates of acute rejection during the first year after transplantation in the mTORi-Tac (6.4%) group compared with Tac-MMF (11.2%). Obesity class 1 (30 < BMI < 35 kg/m2) was associated with a significant risk of acute rejection for the mTORi-Tac group [obesity class 1 hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.21–2.62, P = .003]. A similar trend was observed in the Tac-MMF group for advanced obesity HR 1.29; 95% CI 0.96–1.73, P = .087). For the Tac-MMF group, recipients with both overweight and obesity had significantly impaired survival due to cardiovascular events and also increased mortality due to infection in advanced obesity. Combination of mTORi and calcineurin inhibitor was associated with lower rejection rates and stable long-term kidney function while reducing cardiovascular side effects linked to calcineurin inhibitors in obese kidney graft recipients.
Conclusion
These results are critical for the growing number of obese graft recipients and warrant prospective evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Clinical Epidemiology and Applied Biostatistics, Medical University of Tübingen, Tübingen, Germany.
- Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
- Department of Diabetology, Endocrinology, Nephrology, Section of Nephrology and Hypertension, University Hospital Tübingen, Tübingen, Germany.
- Department of Pharmacology, Experimental Therapy & Toxicology and Interfaculty Center of Pharmacogenomics & Drug Research (IZePhA), University Hospitals and Clinics, Eberhard Karls University Tübingen, Tübingen, Germany.
ORCID-Profile: Andrea Della Penna, Martina Guthoff, Alfred Königsrainer
Zitieren
APA
Serna-Higuita, L. M., Della Penna, A., Guthoff, M., Heyne, N., Beer-Hammer, S., Nadalin, S., Martus, P., Königsrainer, A., & Quante, M. (2023). Impact of different immunosuppressive protocols on clinical outcomes in obese kidney transplant recipients: a propensity score–matched analysis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad014
Vancouver
Serna-Higuita LM, Della Penna A, Guthoff M, Heyne N, Beer-Hammer S, Nadalin S, et al. Impact of different immunosuppressive protocols on clinical outcomes in obese kidney transplant recipients: a propensity score–matched analysis. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfad014
BibTeX
@article{SernaHiguita2023,
author = {Serna-Higuita, Lina Maria and Della Penna, Andrea and Guthoff, Martina and Heyne, Nils and Beer-Hammer, Sandra and Nadalin, Silvio and Martus, Peter and Königsrainer, Alfred and Quante, Markus},
title = {Impact of different immunosuppressive protocols on clinical outcomes in obese kidney transplant recipients: a propensity score–matched analysis},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
doi = {10.1093/ndt/gfad014}
}
EUVIMED